16238-Prostate Cancer-NA-617

Prostate Cancer

TRITON3: A Multicenter, Randomized, Open-label Phase 3 Study of Rucaparib versus Physician's Choice of Therapy for Patients with Metastatic Castration-resistant Prostate Cancer Associated with Homologous Recombination Deficiency (CO-338-063)

  • Details

ClinicalTrials.gov ID: NCT02975934
Diagnosis Type: NA
USOR Number: 16238

  • Address

5400 Kell West Blvd
Wichita Falls, TX 76310
P: (940) 691-8271

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.